National Institute of Neurological Disorders and Stroke, 46847 [2014-18849]

Download as PDF Federal Register / Vol. 79, No. 154 / Monday, August 11, 2014 / Notices Committee must notify the Contact Person listed on this notice by 5:00 p.m. ET on Friday, September 12, 2014, with their request to present oral comments at the meeting. Interested individuals and representatives of organizations must submit a written/electronic copy of the oral statement/comments including a brief description of the organization represented by 5:00 p.m. ET on Wednesday, September 17, 2014. 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS). Dated: August 1, 2014. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2014–18857 Filed 8–8–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke mstockstill on DSK4VPTVN1PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of an Interagency Pain Research Coordinating Committee (IPRCC) meeting. The meeting will feature invited speakers and discussions of committee business items including strategic planning for Federal pain research and the National Pain Strategy. The meeting will be open to the public and accessible by live webcast and conference call. Name of Committee: Interagency Pain Research Coordinating Committee. Type of meeting: Open Meeting. Date: September 24, 2014. Time: 8:30 a.m. to 5:00 p.m. *Eastern Time*—Approximate end time. Agenda: The meeting will feature invited speakers and discussions of Committee business items including the National Pain Strategy and long term strategic planning for Federal pain research. Place: National Institutes of Health, Building 31, C Wing, 6th Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892. Call in Teleconference Line (Listen Only): Dial: 888–945–5891, Participant Passcode: 1242293. Cost: The meeting is free and open to the public. Webcast Live: http://videocast.nih.gov/. Deadlines: Notification of intent to present oral comments: Friday, September 12, 2014, by 5:00 p.m. ET. Submission of written/electronic statement for oral comments: Wednesday, September 17, 2014, by 5:00 p.m. ET. Submission of written comments: Friday, September 19, 2014, by 5:00 p.m. ET. Access: Medical Center Metro (Red Line), Visitor Information: http://www.nih.gov/ about/visitor/index.htm. Contact Person: Linda L. Porter, Ph.D., Pain Policy Advisor, Office of Pain Policy, Officer of the Director, National Institute of Neurological Disorders and Stroke, NIH, 31 Center Drive, Room 8A03, Bethesda, MD 20892, Phone: (301) 451–4460, Email: Linda.Porter@nih.gov. Please Note: Any member of the public interested in presenting oral comments to the VerDate Mar<15>2010 17:35 Aug 08, 2014 Jkt 232001 Statements submitted will become a part of the public record. Only one representative of an organization will be allowed to present oral comments on behalf of that organization, and presentations will be limited to three to five minutes per speaker, depending on number of speakers to be accommodated within the allotted time. Speakers will be assigned a time to speak in the order of the date and time when their request to speak is received, along with the required submission of the written/ electronic statement by the specified deadline. If special accommodations are needed, please email the Contact Person listed above. In addition, any interested person may submit written comments to the IPRCC prior to the meeting by sending the comments to the Contact Person listed on this notice by 5:00 p.m. ET, Friday, September 19, 2014. The comments should include the name and, when applicable, the business or professional affiliation of the interested person. All written comments received by the deadlines for both oral and written public comments will be provided to the IPRCC for their consideration and will become part of the public record. The meeting will be open to the public through a conference call phone number and webcast live on the Internet. Members of the public who participate using the conference call phone number will be able to listen to the meeting but will not be heard. If you experience any technical problems with the conference call or webcast, please call Operator Service on (301) 496–4517 for conference call issues and the NIH IT Service Desk at (301) 496–4357, toll free (866) 319–4357, for webcast issues. Individuals who participate in person or by using these electronic services and who need special assistance, such as captioning of the conference call or other reasonable accommodations, should submit a request to the Contact Person listed on this notice at least seven days prior to the meeting. As a part of security procedures, attendees should be prepared to present a photo ID during the security process to get on the NIH campus. For a full description, please see: http:// www.nih.gov/about/visitorsecurity.htm. PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 46847 Information about the IPRCC is available on the Web site: http:// iprcc.nih.gov/. Dated: August 4, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–18849 Filed 8–8–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Announcement of Requirements and Registration for ‘‘Follow that Cell’’ Challenge Authority: 15 U.S.C. 3719. Through the ‘‘Follow that Cell’’ Challenge (the ‘‘Challenge’’), the Single Cell Analysis Program (SCAP)— http://commonfund.nih.gov/Singlecell/ index, a component of the National Institutes of Health Common Fund— http://commonfund.nih.gov/about, is searching for novel methods for analyzing dynamic states of individual cells that can serve as the basis for predicting alterations in cell behavior and function over time. The goal of the Challenge is to develop new tools and methods that allow time-dependent measurements at the single-cell level in a complex tissue environment in order to assess functional changes, provide information on the health status of a given cell, and help guide diagnosis and therapeutic treatments related to human disease states. Technological breakthroughs in this arena could allow researchers and physicians to identify rare cells in a mixed population, such as individual cells that can transform and become cancerous, cells that are latently infected with a pathogenic virus, or cells that develop resistance to drugs over time. The NIH Common Fund currently supports SCAP grants, the majority of which are associated with academic institutions. This Challenge, structured in two phases, will strengthen and complement the existing SCAP grant portfolio by reaching out to a more diverse population of innovators and solvers, including not only those who are from academic institutions but also those who are from research and development communities in the private sector and those who are outside biomedical disciplines. The NIH believes this Challenge will stimulate investment from both public and private sectors in single-cell analysis research and product development, which, in SUMMARY: E:\FR\FM\11AUN1.SGM 11AUN1

Agencies

[Federal Register Volume 79, Number 154 (Monday, August 11, 2014)]
[Notices]
[Page 46847]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-18849]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of an Interagency Pain 
Research Coordinating Committee (IPRCC) meeting.
    The meeting will feature invited speakers and discussions of 
committee business items including strategic planning for Federal pain 
research and the National Pain Strategy.
    The meeting will be open to the public and accessible by live 
webcast and conference call.

    Name of Committee: Interagency Pain Research Coordinating 
Committee.
    Type of meeting: Open Meeting.
    Date: September 24, 2014.
    Time: 8:30 a.m. to 5:00 p.m. *Eastern Time*--Approximate end 
time.
    Agenda: The meeting will feature invited speakers and 
discussions of Committee business items including the National Pain 
Strategy and long term strategic planning for Federal pain research.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
    Call in Teleconference Line (Listen Only): Dial: 888-945-5891, 
Participant Passcode: 1242293.
    Cost: The meeting is free and open to the public.
    Webcast Live: http://videocast.nih.gov/.
    Deadlines: Notification of intent to present oral comments: 
Friday, September 12, 2014, by 5:00 p.m. ET.
    Submission of written/electronic statement for oral comments: 
Wednesday, September 17, 2014, by 5:00 p.m. ET.
    Submission of written comments: Friday, September 19, 2014, by 
5:00 p.m. ET.
    Access: Medical Center Metro (Red Line), Visitor Information: 
http://www.nih.gov/about/visitor/index.htm.
    Contact Person: Linda L. Porter, Ph.D., Pain Policy Advisor, 
Office of Pain Policy, Officer of the Director, National Institute 
of Neurological Disorders and Stroke, NIH, 31 Center Drive, Room 
8A03, Bethesda, MD 20892, Phone: (301) 451-4460, Email: 
Linda.Porter@nih.gov.


    Please Note: Any member of the public interested in presenting 
oral comments to the Committee must notify the Contact Person listed 
on this notice by 5:00 p.m. ET on Friday, September 12, 2014, with 
their request to present oral comments at the meeting. Interested 
individuals and representatives of organizations must submit a 
written/electronic copy of the oral statement/comments including a 
brief description of the organization represented by 5:00 p.m. ET on 
Wednesday, September 17, 2014.

    Statements submitted will become a part of the public record. Only 
one representative of an organization will be allowed to present oral 
comments on behalf of that organization, and presentations will be 
limited to three to five minutes per speaker, depending on number of 
speakers to be accommodated within the allotted time. Speakers will be 
assigned a time to speak in the order of the date and time when their 
request to speak is received, along with the required submission of the 
written/electronic statement by the specified deadline. If special 
accommodations are needed, please email the Contact Person listed 
above.
    In addition, any interested person may submit written comments to 
the IPRCC prior to the meeting by sending the comments to the Contact 
Person listed on this notice by 5:00 p.m. ET, Friday, September 19, 
2014. The comments should include the name and, when applicable, the 
business or professional affiliation of the interested person. All 
written comments received by the deadlines for both oral and written 
public comments will be provided to the IPRCC for their consideration 
and will become part of the public record.
    The meeting will be open to the public through a conference call 
phone number and webcast live on the Internet. Members of the public 
who participate using the conference call phone number will be able to 
listen to the meeting but will not be heard. If you experience any 
technical problems with the conference call or webcast, please call 
Operator Service on (301) 496-4517 for conference call issues and the 
NIH IT Service Desk at (301) 496-4357, toll free (866) 319-4357, for 
webcast issues.
    Individuals who participate in person or by using these electronic 
services and who need special assistance, such as captioning of the 
conference call or other reasonable accommodations, should submit a 
request to the Contact Person listed on this notice at least seven days 
prior to the meeting.
    As a part of security procedures, attendees should be prepared to 
present a photo ID during the security process to get on the NIH 
campus. For a full description, please see: http://www.nih.gov/about/visitorsecurity.htm.
    Information about the IPRCC is available on the Web site: http://iprcc.nih.gov/.

    Dated: August 4, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-18849 Filed 8-8-14; 8:45 am]
BILLING CODE 4140-01-P